Clinical Diagnostics

Selected news for the healthcare topic - Clinical Diagnostics, collected since 10/2017. There are 4.9K items in the archive. This healthcare topic shares news with COVID-19, Infectious Disease, Siemens, Thermo Fisher, Morgan Stanley and hundreds of others.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source Relevant Snippet
6/6/2022 Point72 Asset Management L.P. Lowers Position in Ortho Clinical Diagnostics Holdings plc (NASDAQ:OCDX) baseballnewssource.com Point72 Asset Management L.P. lessened its position in Ortho Clinical Diagnostics Holdings plc ( NASDAQ:OCDX – Get Rating ) by 68.2% in the fourth quarter, HoldingsChannel reports. The firm owned 240,000 shares of the company’s stock after selling 514,667 shares during the quarter. Point72 Asset Management L.P.’s holdings in Ortho Clinical Diagnostics were worth $5,134,000 as of its most recent SEC filing.Several other institutional investors and hedge funds ...
6/6/2022 Point72 Asset Management L.P. Reduces Stake in Ortho Clinical Diagnostics Holdings plc (NASDAQ:OCDX) zolmax.com Point72 Asset Management L.P. reduced its holdings in Ortho Clinical Diagnostics Holdings plc ( NASDAQ:OCDX – Get Rating ) by 68.2% during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 240,000 shares of the company’s stock after selling 514,667 shares during the quarter. Point72 Asset Management L.P. owned 0.11% of Ortho Clinical Diagnostics worth $5,134,000 at the end of the ...
6/6/2022 Nuveen Asset Management LLC Has $34.63 Million Stake in Ortho Clinical Diagnostics Holdings plc (NASDAQ:OCDX) baseballnewssource.com Nuveen Asset Management LLC increased its holdings in Ortho Clinical Diagnostics Holdings plc ( NASDAQ:OCDX – Get Rating ) by 25.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,618,743 shares of the company’s stock after buying an additional 329,445 shares during the period. Nuveen Asset Management LLC’s holdings in Ortho Clinical ...
6/3/2022 Eaton Vance Management Has $31.69 Million Position in Ortho Clinical Diagnostics Holdings plc (NASDAQ:OCDX) - WKRB News wkrb13.com Eaton Vance Management lowered its position in Ortho Clinical Diagnostics Holdings plc ( NASDAQ:OCDX – Get Rating ) by 19.2% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,481,654 shares of the company’s stock after selling 352,642 shares during the quarter. Eaton Vance Management owned 0.67% of Ortho Clinical Diagnostics worth $31,693,000 as of its most recent filing ...
6/3/2022 Eaton Vance Management Decreases Stake in Ortho Clinical Diagnostics Holdings plc (NASDAQ:OCDX) Daily Political Eaton Vance Management lowered its position in Ortho Clinical Diagnostics Holdings plc ( NASDAQ:OCDX – Get Rating ) by 19.2% in the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 1,481,654 shares of the company’s stock after selling 352,642 shares during the quarter. Eaton Vance Management’s holdings in Ortho Clinical Diagnostics were worth $31,693,000 as of its most recent SEC ...
6/3/2022 Eaton Vance Management Has $31.69 Million Position in Ortho Clinical Diagnostics Holdings plc (NASDAQ:OCDX) thecerbatgem.com Eaton Vance Management lowered its position in Ortho Clinical Diagnostics Holdings plc ( NASDAQ:OCDX – Get Rating ) by 19.2% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,481,654 shares of the company’s stock after selling 352,642 shares during the quarter. Eaton Vance Management owned 0.67% of Ortho Clinical Diagnostics worth $31,693,000 as of its most recent filing ...
6/3/2022 New Analysis from Global Industry Analysts Reveals Steady Growth for RNA Analysis / Transcriptomics, with the Market to Reach $10.5 Billion Worldwide by 2026 PR Newswire ... Thermo Fisher Scientific Inc.; Waters Corporation and Others. Coverage: All major geographies and key segments Segments: Product (Reagents / Consumables, Instruments, Services, Software); Technology (Polymerase Chain Reaction, Sequencing, Microarray, RNA Interference); Application (Drug Discovery, Toxicogenomics, Clinical Diagnostics , Comparative Transcriptomics) Geographies: World; USA ; Canada ; Japan ; China ; Europe ; France ; Germany ; Italy ; UK; Rest of Europe ; Asia-Pacific ; Rest of World.Complimentary Project Preview - This is an ongoing global program. Preview our research program ...
6/1/2022 Dr. Funda Suer Joins Quadrant Biosciences as EVP of Clinical Diagnostics and CLIA Laboratory Director | Business & Finance | citizentribune.com citizentribune.com Suer to expand molecular genetic testing portfolio at QuadrantSYRACUSE, N.Y., May 31, 2022 /PRNewswire/ -- Quadrant Biosciences Inc., a developer of novel molecular diagnostics, announced that Dr. Funda Suer has joined the company as Executive Vice President of Clinical Diagnostics and CLIA Laboratory Director. In this role, Funda will lead and support Laboratory Services in the development and adoption of new assays.Dr. Suer joins Quadrant from Mount Sinai Genomics ...
6/1/2022 Dr. Funda Suer Joins Quadrant Biosciences as EVP of Clinical Diagnostics and CLIA Laboratory Director | Business | The Daily News galvnews.com Suer to expand molecular genetic testing portfolio at QuadrantSYRACUSE, N.Y., May 31, 2022 /PRNewswire/ -- Quadrant Biosciences Inc., a developer of novel molecular diagnostics, announced that Dr. Funda Suer has joined the company as Executive Vice President of Clinical Diagnostics and CLIA Laboratory Director. In this role, Funda will lead and support Laboratory Services in the development and adoption of new assays.Dr. Suer joins Quadrant from Mount Sinai Genomics ...
5/31/2022 Flow Cytometry Market To Surpass $10,065.4 Million Revenue by 2030: P&S Intelligence PR Newswire ... likely to reach $10,065.4 million by 2030, propelling at an 8.4% CAGR from 2021 to 2030. This will mainly be because of the growth in drug development, increase in the demand for analysis in clinical diagnostics , and the usage of flow cytometry for research purposes. For instance, this technology is widely used in in-vitro molecular studies and cancer research.Healthcare centers accomplish immunophenotyping for the analysis of primary immunodeficiency ...
5/31/2022 Dr. Funda Suer Joins Quadrant Biosciences as EVP of Clinical Diagnostics and CLIA Laboratory Director Yahoo News Suer to expand molecular genetic testing portfolio at QuadrantSYRACUSE, N.Y. , May 31, 2022 /PRNewswire/ -- Quadrant Biosciences Inc., a developer of novel molecular diagnostics, announced that Dr. Funda Suer has joined the company as Executive Vice President of Clinical Diagnostics and CLIA Laboratory Director. In this role, Funda will lead and support Laboratory Services in the development and adoption of new assays.Fundu Suer, PhD, ACMG, DABMGG Dr. Suer joins ...
5/29/2022 Europe Immunochemistry Reagents Market 2022 In-Depth Research Framework with Revenue Share By Manufacturers “Roche Diagnostics, Thermo Fisher Scientific, Ortho Clinical Diagnostics, Bio-Rad” dailyresearchsheets.com Europe Immunochemistry Reagents Market 2022 In-Depth Research Framework with Revenue Share By Manufacturers “Roche Diagnostics, Thermo Fisher Scientific, Ortho Clinical Diagnostics, Bio-Rad”Immunochemistry Reagents Market Size and Forecast (2022-2028)The study examines the impact of these key trends in detail and outlines the growth opportunities in various segments on the basis of how these trends will shape the Immunochemistry Reagents market going forward.Latest Update: This has ...
5/28/2022 Ghisallo Capital Management LLC Sells 426,864 Shares of Ortho Clinical Diagnostics Holdings plc (NASDAQ:OCDX) com-unik.info Ghisallo Capital Management LLC lessened its stake in Ortho Clinical Diagnostics Holdings plc ( NASDAQ:OCDX – Get Rating ) by 54.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 350,000 shares of the company’s stock after selling 426,864 shares during the period. Ghisallo Capital Management LLC owned about 0.16% of Ortho Clinical Diagnostics worth $7,487,000 at the ...
5/28/2022 QuidelOrtho Formed by the Completion of Transaction Combining Quidel and Ortho Clinical Diagnostics caribbeannewsglobal.com ... the William Blair 42nd Annual Growth Stock Conference June 8, 2022SAN DIEGO–(BUSINESS WIRE)–QuidelOrtho Corporation (NASDAQ: QDEL) (“QuidelOrtho”) announced completion of the transaction combining Quidel Corporation (“Quidel”) and Ortho Clinical Diagnostics Holdings plc (“Ortho”), creating QuidelOrtho, a leading in vitro diagnostics company. The new company, headquartered in San Diego, California, generated more than $3.5 billion in combined revenues in 2021 and has approximately 6,000 ...
5/27/2022 Ortho Clinical Diagnostics Holdings plc (OCDX) is offering a Buy-In Opportunity investchronicle.com Let’s start up with the current stock price of Ortho Clinical Diagnostics Holdings plc (OCDX), which is $17.63 to be very precise. The Stock rose vividly during the last session to $17.79 after opening rate of $17.58 while the lowest price it went was recorded $17.465 before closing at $17.55.Recently in News on May 26, 2022, Quidel and Ortho Announce Expected Closing of Ortho Transaction. Quidel Corporation (NASDAQ ...
5/27/2022 In Brief This Week: Quidel, Ortho Clinical Diagnostics, T2 Biosystems, Agilent Technologies, More | 360Dx 360dx.com NEW YORK – Quidel announced this week the completion of its combination with Ortho Clinical Diagnostics, creating QuidelOrtho. The company will be headquartered in San Diego, has approximately 6,000 employees, and will trade on the Nasdaq under the ticker symbol QDEL. The combined firm generated more than $3.5 billion in revenues in 2021.Under the terms of the agreement governing the transaction, former Ortho Clinical Diagnostics shareholders received $7.14 in ...
5/27/2022 Quidel and Ortho Clinical Diagnostics complete merger to form QuidelOrtho jhconline.com May 27, 2022 – QuidelOrtho Corporation announced completion of the transaction combining Quidel Corporation and Ortho Clinical Diagnostics Holdings plc, creating QuidelOrtho, a leading in vitro diagnostics company.The new company, headquartered in San Diego, California, generated more than $3.5 billion in combined revenues in 2021 and has approximately 6,000 employees. QuidelOrtho will trade on the Nasdaq Global Select Market under the symbol “QDEL.”The QuidelOrtho board is composed ...
5/27/2022 Investors finally get a glimpse of Ortho Clinical Diagnostics Holdings plc (OCDX) volume hitting the figure of 5.85 million. newsdaemon.com Ortho Clinical Diagnostics Holdings plc (NASDAQ: OCDX) kicked off on May 26, 2022, at the price of $17.58, up 0.46% from the previous trading day. During the day, the shares moved up to $17.79 and dropped to $17.465 before settling in for the closing price of $17.55. Over the past 52 weeks, OCDX has traded in a range of $16.04-$22.99.It was noted that within the last five years ...
5/27/2022 Ortho Clinical Diagnostics Holdings plc [OCDX] Stock trading around $17.63 per share: What's Next? dbtnews.com Ortho Clinical Diagnostics Holdings plc [OCDX] Stock trading around $17.63 per share: What’s Next? Finance By Brandon Evans May 27, 2022 Related Finance Ortho Clinical Diagnostics Holdings plc [OCDX] Stock trading around $17.63 per share: What’s Next? Ortho Clinical Diagnostics Holdings plc traded at a... Read more Companies Healthcare Trust of America Inc. [HTA] fell -11.71% so far this year. What now? Healthcare Trust of America Inc. price ...
5/27/2022 Quidel and Ortho Clinical Diagnostics complete merger to form QuidelOrtho repertoiremag.com May 27, 2022 – QuidelOrtho Corporation announced completion of the transaction combining Quidel Corporation and Ortho Clinical Diagnostics Holdings plc, creating QuidelOrtho, a leading in vitro diagnostics company.The new company, headquartered in San Diego, California, generated more than $3.5 billion in combined revenues in 2021 and has approximately 6,000 employees. QuidelOrtho will trade on the Nasdaq Global Select Market under the symbol “QDEL.”The QuidelOrtho board is composed ...